This study describes the social and communicative strategies pharmaceutical companies use to influence NSAID prescribing behaviors and elicits physicians' perceptions and counterbalances to these strategies.
A program identifying and resolving care gaps involving community pharmacists resulted in increased adherence and omission gaps closure and fewer adherence gap reopenings.
Self-testing of anticoagulation improves outcomes, but is expensive. One might assume it is more helpful for patients living farther from care, but the authors disprove this assumption.
This study demonstrates that it is possible to generate a highly accurate model to predict inpatient and emergency department utilization using data on socioeconomic determinants of care.
Accountable care organizations will be more successful in taking on accountability for patient outcomes when market and firm organization get a balanced treatment.
Patients with diabetes that are cared for by primary care teams with higher cohesion experienced greater EHR-related outcome improvements, compared with patients cared for by lower cohesion teams.
High-deductible benefit design was associated with increased out-of-pocket costs for maternity care, but had no adverse impacts on receipt of recommended prenatal and postpartum care.
This study compares the performance of several definitions of concurrent adherence to related medications.
A discussion of chronic pain prevalence, care obstacles, and potential opportunities for care improvement within the accountable care organization context at University of California, San Francisco Health.
National survey reveals primary care physicians have low knowledge of consumer-directed health plans and limited readiness to engage patients on issues of cost and quality.
Editor's Note: A book by Kashyap Patel, MD, reviewed in the April issue of Evidence-Based Oncology™, was previously titled, Dying Without Fear. Due to a change by the publisher, Penguin Random House India, the book is now titled Between Life and Death: From Despair to Hope. The book is available August 1, 2020 This review has been updated to reflect the change in the book's title.
An observational study of 42 successful programs to improve primary care management of cardiovascular risk showed the impact of a strong primary care system.
The Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018, which reauthorizes a sickle cell disease prevention and treatment program and provides grants for research, surveillance, prevention, and treatment of heritable blood disorders, has passed Congress and been signed into law.
The field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions. Using an online platform with an engaged patient community, we developed and psychometrically validated a new measure in just under a year.
Comparative effectiveness research and pragmatic clinical trials are valued methods to address the limitations of traditional randomized trials, answer questions of cost-effectiveness or noninferiority, and inform data-driven dialogue and decision making by stakeholders.
Diverse patients experience disparities in care transitions. A survey of 224 patients showed differences by race, ethnicity, and language in technology access and in patient worries post discharge.
On average, the health coach intervention cost $483 per participant per year. There was no evidence that the coaching intervention saved money at 1 year.